
Siemens closes in on CTI acquisitionAs of May 4, 94% of the outstanding shares of CTI Molecular Imaging had been acquired by Siemens Medical Solutions as part of that company’s bid to acquire the Knoxville, TN, firm. Siemens expects to complete the acquisition through a merger in which all CTI shares not validly tendered will be converted into the right to receive $20.50 per share. CTI would then become a wholly owned subsidiary of Siemens Medical Solutions. CTI Molecular Imaging is a supplier of PET products and services with annual revenues above $400 million and annual income near $60 million.








